检索范围:
排序: 展示方式:
Genomics and genetic breeding in aquatic animals: progress and prospects
Wenteng XU, Songlin CHEN
《农业科学与工程前沿(英文)》 2017年 第4卷 第3期 页码 305-318 doi: 10.15302/J-FASE-2017154
Sepsis biomarkers: an omics perspective
null
《医学前沿(英文)》 2014年 第8卷 第1期 页码 58-67 doi: 10.1007/s11684-014-0318-2
Sepsis is a common cause of death in hospitalized patients worldwide. The early detection of sepsis remains a great challenge for clinicians, and delayed diagnosis frequently undermines treatment efforts, thereby contributing to high mortality. Omics technologies allow high-throughput screening of sepsis biomarkers. This review describes currently available and novel sepsis biomarkers in the context of genomics, transcriptomics, proteomics, and metabolomics. The combination of these technologies can help refine the diagnosis of sepsis. This review paper serves as a reference for future studies that employ an integrated, multi-omics approach to disease identification.
关键词: sepsis biomarker genomics transcriptomics proteomics metabolomics
An introduction to the medicinal plant genome project
Shilin Chen, Li Xiang, Xu Guo, Qiushi Li
《医学前沿(英文)》 2011年 第5卷 第2期 页码 178-184 doi: 10.1007/s11684-011-0131-0
Do not let precision medicine be kidnapped
null
《医学前沿(英文)》 2015年 第9卷 第4期 页码 512-513 doi: 10.1007/s11684-015-0425-8
Obama’s precision medicine initiative made the medical community boil over after the initiative’s release. Precision medicine has been advocated by the majority of scientists and doctors. However, some experts have questioned this concept. This article does not oppose precision medicine. However, the incentive of vigorously promoting precision medicine at present is a concern.
Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia
null
《医学前沿(英文)》 2015年 第9卷 第1期 页码 1-9 doi: 10.1007/s11684-015-0381-3
With the cure rate of childhood acute lymphoblastic leukemia (ALL) approaching 90%, further improvement in the treatment outcome and quality of life of patients will require better understanding of the mechanisms of drug resistance, identifying new leukemic cell genetic lesions that are amendable to available target therapy, and optimizing treatment based on host pharmacodynamics and pharmacogenomics. Deeper characterization of leukemic cell genetic abnormalities has discovered new subtypes of leukemia such as early T-cell precursor ALL and Philadelphia chromosome-like ALL, and identified many genomic alterations that have diagnostic, prognostic, or therapeutic implications. In this regard, several novel fusion transcripts are responsive to ABL tyrosine kinase inhibitors and potentially to JAK inhibitors. Genome-wide analyses have also unraveled the role of inherited cancer predisposing genes and small nucleotide polymorphisms of several genes in the development of childhood ALL. These advances promise to lead to more sophisticated personalized treatment strategies in the near future.
关键词: pharmacogenomics acute lymphoblastic leukemia genomics pharmacogenetics
Genomics approaches to unlock the high yield potential of cassava, a tropical model plant
Shengkui ZHANG,Ping’an MA,Haiyan WANG,Cheng LU,Xin CHEN,Zhiqiang XIA,Meiling ZOU,Xinchen ZHOU,Wenquan WANG
《农业科学与工程前沿(英文)》 2014年 第1卷 第4期 页码 259-266 doi: 10.15302/J-FASE-2014043
关键词: cassava genomics yield potential adaptability tropical model
Recent advances in fruit crop genomics
Qiang XU,Chaoyang LIU,Manosh Kumar BISWAS,Zhiyong PAN,Xiuxin DENG
《农业科学与工程前沿(英文)》 2014年 第1卷 第1期 页码 21-27 doi: 10.15302/J-FASE-2014002
深古菌门的核心代谢功能和热环境起源 Article
冯晓远, 王寅炤, Rahul Zubi, 王风平
《工程(英文)》 2019年 第5卷 第3期 页码 498-504 doi: 10.1016/j.eng.2019.01.011
深古菌门具有复杂的亚群分类,是地球上丰度最高的微生物之一。然而,深古菌的代谢特征和演化历史仍然有待进一步研究。本研究对来自10个不同亚群的15个新获得和36个已经发表的深古菌基因组进行了比较基因组分析,揭示了深古菌门的核心代谢特征,即蛋白质、脂质、芳香族化合物降解,糖酵解途径和Wood–Ljungdahl (WL) 途径。上述核心代谢特征表明深古菌使用乙酰辅酶A作为重要的代谢中间物。此外,部分深古菌亚群还具有不完整的柠檬酸循环、产乙酸途径和硫化物相关的代谢潜能,表明不同亚群具有多样的代谢能力和生态功能。亚群Bathy-21和Bathy-22位于深古菌系统发育树根部,是目前已知最古老的两个深古菌亚群。它们广泛分布于热液(泉)环境中,并编码超嗜热适应性特征的标记基因逆促旋酶(reverse gyrase, rgy)。综上,本研究对深古菌门的核心代谢能力进行了系统性研究和总结,并揭示了深古菌热环境起源的演化历史。
人类蛋白质N-糖基化的十二年全基因组关联研究 Review
Anna Timoshchuk, Sodbo Sharapov, Yurii S. Aulchenko
《工程(英文)》 2023年 第26卷 第7期 页码 17-31 doi: 10.1016/j.eng.2023.03.013
Most human-secreted and membrane-bound proteins have covalently attached oligosaccharide chains, or glycans. Glycosylation influences the physical and chemical properties of proteins, as well as their biological functions. Unsurprisingly, alterations in protein glycosylation have been implicated in a growing number of human diseases, and glycans are increasingly being considered as potential therapeutic targets, an essential part of therapeutics, and biomarkers. Although glycosylation pathways are biochemically well-studied, little is known about the networks of genes that guide the cell- and tissue-specific regulation of these biochemical reactions in humans in vivo. The lack of a detailed understanding of the mechanisms regulating glycome variation and linking the glycome to human health and disease is slowing progress in clinical applications of human glycobiology. Two of the tools that can provide much sought-after knowledge of human in vivo glycobiology are human genetics and genomics, which offer a powerful data-driven agnostic approach for dissecting the biology of complex traits. This review summarizes the current state of human populational glycogenomics. In Section 1, we provide a brief overview of the N-glycan's structural organization, and in Section 2, we give a description of the major blood plasma glycoproteins. Next, in Section 3, we summarize, systemize, and generalize the results from current N-glycosylation genome-wide association studies (GWASs) that provide novel knowledge of the genetic regulation of the populational variation of glycosylation. Until now, such studies have been limited to an analysis of the human blood plasma N-glycome and the N-glycosylation of immunoglobulin G and transferrin. While these three glycomes make up a rather limited set compared with the enormous multitude of glycomes of different tissues and glycoproteins, the study of these three does allow for powerful analysis and generalization. Finally, in Section 4, we turn to genes in the established loci, paying particular attention to genes with strong support in Section 5. At the end of the review, in Sections 6 and 7, we describe special cases of interest in light of new discoveries, focusing on possible mechanisms of action and biological targets of genetic variation that have been implicated in human protein N-glycosylation.
新孢子虫病——分子流行病学及发病机制综述 Review
Asis Khan, Jahangheer S. Shaik, Patricia Sikorski, Jitender P. Dubey, Michael E. Grigg
《工程(英文)》 2020年 第6卷 第1期 页码 10-19 doi: 10.1016/j.eng.2019.02.010
犬新孢子虫(Neospora caninum)是一种囊肿形成的原生动物寄生虫,它是世界范围内牛的流产和新生儿死亡的主要原因。犬新孢子虫具有广泛的中间宿主范围,其有性繁殖只在犬科动物中发生。另一种新孢子虫——休斯新孢子虫也已经被发现,它能导致马的脑髓炎。虽然分子流行病学研究尚处于起步阶段,但核糖体小亚单位RNA(small subunit ribosomal RNA, ssuRNA)和犬新孢子虫物种特异性DNA探针(pNc5)中的18S rRNA和ITS1区域已被广泛应用于区分新孢子虫和其他密切相关的顶复门寄生虫。虽然这些重复区域比管家或抗原基因具有更高的敏感性和特异性,但它们具有较低的区分能力,无法捕捉物种内部的多样性。同样,尽管多个小卫星或微卫星标记研究显示了新孢子虫体内清晰的地理亚结构,但由于不同等位基因的大小在微卫星位点上趋同(称为同形质),虫株往往被错误分类。只有一株名为N. caninum Liverpool(Nc-Liv)的虫株被进行基因组测序,并与其近亲弓形虫(Toxoplasma gondii)进行了比较。因此,需要基于全世界多个虫株的全基因组序列进行详细的群体基因组学研究,以便更好地了解新孢子虫目前的种群遗传结构,最终
确定能够更有效对抗牛新孢子虫病的疫苗候选者。本文的目的是概述我们目前对新孢子虫的分子流行病学和基因组学的理解,并将其与密切相关的顶复门寄生虫哈蒙球虫和弓形虫结合起来。
标题 作者 时间 类型 操作
Genomics and genetic breeding in aquatic animals: progress and prospects
Wenteng XU, Songlin CHEN
期刊论文
Genomics approaches to unlock the high yield potential of cassava, a tropical model plant
Shengkui ZHANG,Ping’an MA,Haiyan WANG,Cheng LU,Xin CHEN,Zhiqiang XIA,Meiling ZOU,Xinchen ZHOU,Wenquan WANG
期刊论文
Recent advances in fruit crop genomics
Qiang XU,Chaoyang LIU,Manosh Kumar BISWAS,Zhiyong PAN,Xiuxin DENG
期刊论文